Esomeprazole Magnesium
Product Images NDC 50090-3846

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-3846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Esomeprazole Magnesium Delayed Release Capsules Us 1)

Chemical structure of esomeprazole magnesium shown as a complex with magnesium ion (Mg2+) and two water molecules (2 H2O). The structure displays two esomeprazole molecules coordinated to a magnesium ion, illustrating the molecular arrangement of this compound.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Magnesium Delayed Release Capsules Us 2)

A line graph showing percent maintained on the vertical axis and months on the horizontal axis over a 6-month period. The graph compares Esomeprazole Magnesium Delayed-release Capsules at 40 mg, 20 mg, and 10 mg strengths versus placebo, with each group represented by different line styles and markers. The legend identifies each group and sample sizes. Scheduled visits are marked with 's' on the timeline.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Magnesium Delayed Release Capsules Us 3)

A line graph showing percent maintained over months, comparing Esomeprazole Magnesium Delayed-release Capsules at 40 mg, 20 mg, 10 mg strengths, and placebo. The x-axis represents months from 0 to 6 scheduled visits, and the y-axis shows percent maintained from 0 to 100%. A legend identifies each line by dose and sample size.*

FDA Label Image

Figure 4 (Esomeprazole Magnesium Delayed Release Capsules Us 4)

A line graph showing the percent of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium Delayed-release Capsules 40 mg, 20 mg, and Placebo. The graph compares symptom-free rates, with higher percentages observed for the 40 mg and 20 mg dosages compared to placebo throughout the study period.*

FDA Label Image

Figure 5 (Esomeprazole Magnesium Delayed Release Capsules Us 5)

A line graph depicting the percent of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium Delayed-release Capsules 40 mg, 20 mg, and placebo. The y-axis represents the percent of patients symptom-free (0 to 100%), and the x-axis shows diary days from 0 to 28. Lines indicate improved symptom-free percentages over time for the medication groups compared to placebo.*

FDA Label Image

Label Image (Lbl500903846)

Label for Esomeprazole Magnesium 40 mg delayed-release capsules from A-S Medication Solutions. The label shows product number 6592-0 and package size of 30 delayed-release capsules. Storage instructions are to keep at 77 degrees Fahrenheit. The label includes dosage form and strength details and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.